Company or ticker...

Tango Therapeutics

Tango develops targeted cancer medicines using synthetic lethality biology.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

TNGX

4.2B

68.7

n/a

183.50%

Key Facts

M. Cap

PS

PE

YTD

4.2B

68.7

n/a

183.50%

10MA

20MA

50MA

200MA

$TNGX